{"title":"[儿童白癜风和斑秃:皮肤科医生的观点]。","authors":"Maël Blanchard, David Alvarez Martinez, Marie-Anne Morren, Emmanuel Laffitte, Yassaman Alipour Tehrany","doi":"10.53738/REVMED.2025.21.906.333","DOIUrl":null,"url":null,"abstract":"<p><p>Vitiligo and alopecia areata are chronic autoimmune dermatoses that are relatively common in the pediatric population. Vitiligo is a pigmentation disorder and alopecia areata is a non-scarring alopecia. Both conditions can be highly stigmatizing and have a significant impact on the mental health and quality of life of young patients and their families. There are no large-scale prospective therapeutic studies in the pediatric population. As a result, the expertise of the pediatric dermatologist, along with shared decision-making with the patient and his/her parents, is critical for effective management. This process should carefully consider the individual benefit-risk ratio to ensure the best possible outcome.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 906","pages":"333-338"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Vitiligo and alopecia areata in children : the dermatologist's perspective].\",\"authors\":\"Maël Blanchard, David Alvarez Martinez, Marie-Anne Morren, Emmanuel Laffitte, Yassaman Alipour Tehrany\",\"doi\":\"10.53738/REVMED.2025.21.906.333\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Vitiligo and alopecia areata are chronic autoimmune dermatoses that are relatively common in the pediatric population. Vitiligo is a pigmentation disorder and alopecia areata is a non-scarring alopecia. Both conditions can be highly stigmatizing and have a significant impact on the mental health and quality of life of young patients and their families. There are no large-scale prospective therapeutic studies in the pediatric population. As a result, the expertise of the pediatric dermatologist, along with shared decision-making with the patient and his/her parents, is critical for effective management. This process should carefully consider the individual benefit-risk ratio to ensure the best possible outcome.</p>\",\"PeriodicalId\":21286,\"journal\":{\"name\":\"Revue medicale suisse\",\"volume\":\"21 906\",\"pages\":\"333-338\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue medicale suisse\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53738/REVMED.2025.21.906.333\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale suisse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53738/REVMED.2025.21.906.333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
[Vitiligo and alopecia areata in children : the dermatologist's perspective].
Vitiligo and alopecia areata are chronic autoimmune dermatoses that are relatively common in the pediatric population. Vitiligo is a pigmentation disorder and alopecia areata is a non-scarring alopecia. Both conditions can be highly stigmatizing and have a significant impact on the mental health and quality of life of young patients and their families. There are no large-scale prospective therapeutic studies in the pediatric population. As a result, the expertise of the pediatric dermatologist, along with shared decision-making with the patient and his/her parents, is critical for effective management. This process should carefully consider the individual benefit-risk ratio to ensure the best possible outcome.
期刊介绍:
Destinée aux professionnels de santé, la plateforme revmed.ch regroupe la version électronique de la Revue Médicale Suisse et les applications de formation et d"aide à la prise de décision eRMS. La eRMS est le fruit d’une large collaboration entre institutions et praticiens de Suisse romande.